Patent · US Active

Use of VEGF-C agonists for inhibiting ultraviolet B-induced skin damage

US9192652B2 · kind B2 · utility

0Cited by

14References

17Claims

0Family size

Assignee

The General Hospital Corporation · US

Inventors

Michael Detmar · Arlington, US
Kentaro Kajiya · Yokohama, JP

Key dates

Filing date	Jan 11, 2013
Grant date	Nov 24, 2015
Priority date	—
Expiry date	Jan 11, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG01N2500/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This application features methods of inhibiting ultraviolet B-induced skin damage in a subject. The methods include administering a VEGF-C agonist to the subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.